查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018596

口服注射器市場：按材料、最終用戶、應用和分銷管道分類－2026年至2032年全球市場預測

Oral Syringes Market by Material, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，口服注射器市場價值將達到 10.4 億美元，到 2026 年將成長到 11.2 億美元，到 2032 年將達到 18.2 億美元，複合年成長率為 8.33%。

主要市場統計數據
基準年 2025 10.4億美元
預計年份：2026年 11.2億美元
預測年份 2032 18.2億美元
複合年成長率 (%) 8.33%

一份全面的行業概覽，說明了產品創新、監管重點和不斷發展的醫療保健服務模式如何重新定義口服注射器的優先事項。

口服注射器產業處於醫療設備製造、藥品分發和以病人為中心的醫療保健服務之間的關鍵交匯點。近年來，材料、人體工學設計和給藥精度方面的不斷改進，使口服注射器從單純的給藥裝置轉變為臨床和家庭環境中綜合給藥策略的重要組成部分。同時，監管機構加強了對安全性、標籤和與藥物製劑相容性的監管，促使醫療設備製造商、製藥公司和醫療保健系統之間進行更緊密的合作。

材料、居家照護人體工學、數位化整合和監管期望的進步如何共同改變口服注射器的創新和商業化。

口服注射器的市場格局正受到多項變革性變化的影響，這些變化從根本上改變了產品藍圖和商業策略。首先，材料科學的進步使得輕盈且化學相容性高的注射器成為可能，這些注射器能夠容納更廣泛的製劑，同時又不影響給藥的準確性或病人安全。塑膠配方和玻璃表面處理的創新正在減少藥物洗脫，並改善給藥過程中的使用者體驗，這直接影響患者的用藥依從性。

評估近期關稅變化對口服注射器利害關係人的供應商選擇、籌資策略和供應鏈韌性的影響。

主要經濟體關稅政策的變化會對整個醫療設備供應鏈產生連鎖反應，而美國近期推出的關稅措施為口服注射器製造商、經銷商和採購負責人帶來了新的考量。進口聚合物、模具或成品的關稅上漲增加了依賴國際供應商的企業的採購成本，促使採購團隊重新評估其供應商組合和合約條款。當關稅影響顯著時，企業通常會採取措施穩定價格和供應，例如尋找本地供應商、認證國內替代產品或協商長期合約。

詳細的細分分析揭示了材料選擇、最終用戶情況、應用類型和分銷管道如何塑造獨特的產品和商業策略。

細分市場層面的趨勢揭示了材料選擇、終端用戶環境、應用和分銷管道等方面存在的差異化機會和營運重點。玻璃和塑膠材料的選擇會影響製造流程、監管申報和終端用戶的認知。玻璃通常更適用於需要惰性接觸面和已驗證化學相容性的配方，而塑膠則有利於輕量化設計、射出成型擴充性以及經濟高效的客製化，例如防篡改和符合人體工程學的功能。診所、居家醫療、醫院和藥房等終端使用者群體各​​自提出了不同的需求。診所需要耐用且易於使用的設備供醫護人員使用。居家醫療需要直覺的設計，以最大限度地降低看護者操作和患者自行操作的風險。公立和私立醫院優先考慮消毒相容性、耐用性和採購效率。而藥房則著重於配藥準確性、與包裝的整合以及對患者諮詢的支援。

針對美洲、歐洲、中東和非洲以及亞太地區的獨特需求模式，以及這些區域對生產、監管協調和分銷的影響。

區域趨勢對口服注射器的需求促進因素、監管壓力和供應鏈結構有顯著影響。在美洲，採購系統涵蓋公開競標和私人集團採購組織，某些國家強大的國內生產能力為減少對進口的依賴提供了機會。在北美和拉丁美洲的醫療機構中，居家給藥和門診解決方案的重要性日益凸顯，推動了對便於看護者操作和患者自我給藥的器械的需求，促使製造商相應地調整標籤檢視和說明。

公司層面的關鍵行動和合作夥伴生態系統策略，旨在推動口服注射器領域的差異化、規模化和有效市場進入。

口服注射器生態系內的企業策略正圍繞著幾個明確的要求趨於一致：透過材料和人體工學創新實現產品差異化、關鍵供應鏈的垂直整合，以及透過策略夥伴關係拓展臨床和消費通路的分銷範圍。醫療設備製造商正在投資模具，以縮短客製化設計的上市時間，同時也在尋求可適應特定治療領域的模組化平台。契約製造製造商和專業模具製造商發揮著至關重要的作用，他們提供的擴充性和品管系統使原始設備製造商 (OEM) 能夠響應不斷變化的需求，同時最大限度地減少前置作業時間波動。

為製造商和買家提供可操作的策略重點，以增強韌性，加快在門診環境中的部署，並證明其臨床和經濟價值。

產業領導企業應採取一系列協調一致的舉措，以鞏固市場地位，降低貿易和供應衝擊帶來的風險，並掌握居家和門診護理管道的成長機會。首先，他們應優先投資於兼顧臨床適用性和看護者易用性的材料和設計。一項同步進行化學適用性檢驗和易用性研究的雙管齊下的研發計劃，將有助於加速產品在臨床和居家環境中的推廣應用。其次，他們應實現籌資策略多元化，納入合格的區域供應商並建立策略庫存緩衝。這將降低對單一地區的依賴，並降低關稅和物流風險。

嚴謹、多方面的研究設計，結合監管審查、供應鏈分析、與關鍵相關人員的訪談以及情境分析，確保了可操作的見解。

本研究途徑結合了對公開的監管文件、技術標準和產品文件的系統性綜合分析，以及來自製造、分銷、臨床和居家照護等相關人員的定性一手資訊。二手資料用於梳理過去的政策變化、材料科學的進步和供應鏈趨勢，而一手訪談則用於捕捉採購行為、用戶需求和營運限制等方面的具體細節。調查方法包括供應鏈圖譜繪製，以識別關鍵節點和薄弱環節，以及設計和可用性評估，以評估產品特性與實際使用情境的契合度。

結論強調了卓越設計、供應鏈韌性和策略商業化在確保長期競爭優勢方面的綜合作用。

材料創新、醫療服務模式變革以及採購環節日益謹慎等多重壓力正在重塑口服注射器市場的競爭格局。能夠確保化學相容性並根據看護者和患者的便利性調整產品設計的製造商，將更容易被不同終端使用者群體接受。同時，透過供應商多元化、區域採購和庫存策略來增強供應鏈韌性，對於減輕貿易政策變化和物流中斷對營運的影響仍然至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 口服注射器市場：依材料分類

  • 玻璃
  • 塑膠

第9章 口服注射器市場：依最終用戶分類

  • 診所
  • 居家醫療
    • 由看護者管理
    • 自我管理
  • 醫院
    • 私人的
    • 民眾
  • 藥局

第10章 口服注射器市場：依應用領域分類

  • 人類
  • 獸用

第11章 口服注射器市場：依通路分類

  • 物理藥房
    • 連鎖藥局
    • 獨立經營藥房
  • 網路藥房
    • 電子商務平台
    • 藥局網站

第12章 口服注射器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 口服注射器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 口服注射器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國口服注射器市場

第16章：中國口服注射器市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Amsino International, Inc.
  • AptarGroup, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Gerresheimer AG
  • ICU Medical, Inc.
  • Kindly（KDL）Group
  • Medisafe UK Ltd
  • Medline Industries, LP
  • Nemera SA
  • Nipro Corporation
  • Owen Mumford Ltd.
  • Retractable Technologies, Inc.
  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
Product Code: MRR-B9334AD6C51F

The Oral Syringes Market was valued at USD 1.04 billion in 2025 and is projected to grow to USD 1.12 billion in 2026, with a CAGR of 8.33%, reaching USD 1.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.04 billion
Estimated Year [2026] USD 1.12 billion
Forecast Year [2032] USD 1.82 billion
CAGR (%) 8.33%

Comprehensive sector introduction describing how product innovation, regulatory focus, and evolving care delivery models are redefining oral syringe priorities

The oral syringe sector occupies a critical junction between medical device manufacturing, pharmaceutical dispensing, and patient-centered care delivery. Over recent years, incremental improvements in materials, ergonomic design, and dosing precision have elevated oral syringes from simple dosing implements to components of comprehensive medication administration strategies across clinical and home settings. Regulatory scrutiny has intensified in parallel, focusing on safety, labeling, and compatibility with drug formulations, which in turn has driven closer coordination between device manufacturers, pharmaceutical companies, and health systems.

Supply chain resilience has emerged as a strategic priority, especially for manufacturers that rely on global sourcing for polymers, specialized molds, and packaging materials. At the same time, consumer expectations for ease of use and accuracy in home administration have reshaped product development priorities. Digital patient support services and care pathways are increasingly integrated into the broader value proposition for oral syringes, creating opportunities for bundled offerings that include device, instructions, and digital adherence tools.

Taken together, these dynamics mean manufacturers must balance engineering innovation, regulatory compliance, and distribution agility to remain competitive. Strategic decisions around material selection, channel partnerships, and end-user education will determine which players capture the most durable advantage as care delivery continues to shift toward outpatient and home-based models.

How advances in materials, home-care ergonomics, digital integration, and regulatory expectations are converging to transform oral syringe innovation and commercialization

The landscape for oral syringes is being reshaped by a handful of transformative shifts that are altering product roadmaps and commercial strategies. First, material science advances are enabling lighter, more chemically compatible devices that can accommodate a broader range of formulations without compromising dosing accuracy or patient safety. Innovations in plastics formulation and glass finishing are reducing leachables and improving user sensation during dosing, which has a direct impact on adherence outcomes.

Second, the rise of home healthcare as an established channel is changing design emphasis from clinician-oriented robustness to caregiver- and patient-centered ergonomics. This shift necessitates clearer labeling, tactile feedback, and designs that reduce the risk of dosing error in non-clinical environments. Third, digital integration is accelerating; manufacturers increasingly consider how devices can be paired with apps, smart packaging, or telehealth protocols to support adherence and real-time monitoring.

Finally, regulatory and procurement frameworks are becoming more sophisticated, with an increased appetite from payers and health systems for evidence that devices demonstrably reduce medication errors and improve outcomes. As a result, companies are investing in outcomes research and in partnerships with healthcare providers to validate real-world benefits. Collectively, these shifts are pushing the sector from commodity dynamics toward value-based differentiation.

Assessment of how recent tariff shifts are influencing supplier sourcing, procurement strategies, and supply-chain resilience for oral syringe stakeholders

Tariff policy changes enacted by major economies can have cascading effects across medical device supply chains, and recent tariff actions in the United States have introduced new considerations for oral syringe manufacturers, distributors, and procurers. Higher duties on imported polymers, tooling, or finished components increase landed costs for companies that rely on international supply sources, prompting procurement teams to reassess supplier portfolios and contractual terms. Where tariff impacts are material, organizations often respond by seeking regional suppliers, qualifying domestic equivalents, or negotiating longer-term contracts to stabilize pricing and availability.

Tariffs also alter competitive dynamics; domestic manufacturers that can scale production quickly may gain commercial advantage, while those exposed to imported inputs may need to absorb margin compression or pass costs downstream. For hospitals, pharmacies, and large group purchasers, procurement strategies may shift toward broader supplier diversification and total cost-of-ownership assessments that weigh tariff risk alongside quality and lead time. Regulatory and compliance workflows can be affected as manufacturers change production locations, requiring updated registrations and validation of materials in new jurisdictions.

In addition, tariff-driven sourcing shifts frequently trigger secondary effects such as reconfigured logistics networks, changes in inventory planning, and investment in nearshore manufacturing to reduce exposure. These adaptations require coordinated cross-functional responses that include supply-chain analytics, contracting, and scenario planning to ensure continuity of supply for critical dosing devices.

In-depth segmentation analysis revealing how material choices, end-user contexts, application types, and distribution channels prescribe distinct product and commercial strategies

Segment-level dynamics reveal differentiated opportunities and operational priorities across material choices, end-user contexts, applications, and distribution channels. Material selection between glass and plastic shapes manufacturing pathways, regulatory submissions, and end-user perceptions; glass often appeals to formulations requiring inert contact surfaces and proven chemical compatibility, while plastics enable lightweight designs, injection-mold scalability, and cost-effective customization for tamper-evidence and ergonomic features. End-user segmentation between clinics, home healthcare, hospitals, and pharmacies drives divergent requirements: clinics demand durable, clinician-friendly devices; home healthcare requires intuitive designs for caregiver administered and self administered use cases that minimize dosing risk; hospitals, both private and public, emphasize sterilization compatibility, robustness, and procurement efficiency; and pharmacies focus on dispensing accuracy, packaging integration, and patient counseling support.

Application differentiation between human and veterinary markets affects material tolerances, labeling conventions, and distribution pathways, with veterinary products sometimes exploiting broader packaging and dispensing flexibility. Distribution channel distinctions also guide go-to-market strategies; offline pharmacy outlets, including chain and independent pharmacies, prioritize shelf-ready packaging and pharmacist education, whereas online pharmacy channels, encompassing e-commerce platforms and pharmacy websites, demand fulfillment-friendly designs, clear digital instructions, and returns management provisions. Each segmentation axis implies different product development, regulatory, and commercial investments, and successful providers align design and distribution choices with the dominant requirements of their target segments.

Regional implications for production, regulatory alignment, and distribution that map to distinct demand patterns across the Americas, EMEA, and Asia-Pacific

Regional patterns shape demand drivers, regulatory pressures, and supply-chain configurations for oral syringes in meaningful ways. In the Americas, procurement systems vary between public tenders and private group purchasing organizations, and the presence of strong domestic manufacturing capacity in certain countries offers opportunities to mitigate import exposure. North American and Latin American healthcare settings are increasingly prioritizing home administration and outpatient solutions, which supports demand for devices optimized for caregivers and self-administered dosing and encourages manufacturers to adapt labeling and user instructions accordingly.

In Europe, Middle East & Africa, the regulatory landscape is heterogenous, with well-established regulatory frameworks in parts of Western Europe and evolving systems elsewhere. This results in a dual focus on compliance with stringent European standards and scalable market-entry tactics for emerging markets. Manufacturers operating across this region must navigate complex cross-border logistics, varying sterilization and packaging expectations, and diverse procurement models. Meanwhile, Asia-Pacific exhibits a combination of high-volume manufacturing hubs and rapidly growing domestic demand. The region's manufacturing capabilities support rapid prototyping and cost-efficient production runs, while demographic trends and expanding access to decentralized care drive adoption of user-friendly dosing devices. Supply-chain strategies in Asia-Pacific often emphasize export readiness and regulatory harmonization to serve both regional and global markets.

Critical company-level behaviors and partner ecosystem strategies that drive differentiation, scale, and go-to-market effectiveness in the oral syringe arena

Company strategies in the oral syringe ecosystem are coalescing around a few clear imperatives: product differentiation through material and ergonomic innovation, vertical integration of critical supply inputs, and strategic partnerships that extend distribution reach into clinical and consumer channels. Device manufacturers are investing in tooling that shortens time-to-market for customized designs while pursuing modular platforms that can be adapted for specific therapeutic categories. Contract manufacturers and specialty molders play a pivotal role by offering scalability and quality systems that enable OEMs to respond to shifts in demand with minimal lead-time volatility.

Strategic alliances between device makers, packaging specialists, and digital health providers are becoming more common as firms seek to bundle adherence support and patient education with core devices. On the commercial side, distributors and pharmacy chains are refining category management approaches and analytics capabilities to ensure optimal inventory and to support pharmacist-led patient coaching. Companies that differentiate through robust quality systems, regulatory expertise, and validated supply continuity plans are positioned to succeed in procurement engagements with large health systems and payers. At the same time, nimble innovators that can rapidly test and iterate user-centric features in real-world settings stand to capture acceptance in home healthcare segments more quickly.

Actionable strategic priorities for manufacturers and purchasers to enhance resilience, accelerate adoption in outpatient settings, and demonstrate clinical and economic value

Industry leaders should pursue a coordinated set of actions to strengthen market position, reduce exposure to trade and supply shocks, and capture growth in home and outpatient care channels. First, prioritize material and design investments that address both clinical compatibility and caregiver usability; dual-track R&D programs that validate chemical compatibility and run parallel usability studies will help accelerate adoption across clinical and home settings. Second, diversify sourcing strategies to include qualified regional suppliers and strategic inventory buffers; this reduces dependence on a single geography and mitigates tariff and logistics risks.

Third, build partnerships that enhance distribution and patient support, including collaborations with pharmacy networks and digital adherence providers to create bundled offerings that improve outcomes. Fourth, invest in regulatory and quality infrastructure to speed market entry and support cross-border registrations, with robust change-control procedures that facilitate product line adaptations. Fifth, deploy advanced procurement analytics and scenario planning tools to anticipate cost pressures and optimize total cost of ownership conversations with major buyers. By implementing these actions in parallel, organizations can achieve greater resilience, commercial reach, and demonstrable clinical value.

Rigorous multi-method research design combining regulatory review, supply-chain mapping, primary stakeholder interviews, and scenario analysis to ensure actionable insights

The research approach combined a structured synthesis of public regulatory documentation, technical standards, and product literature with qualitative primary input from stakeholders across manufacturing, distribution, clinical practice, and home-care settings. Secondary sources were used to map historical policy changes, materials science developments, and supply-chain trends, while primary interviews provided contextual nuance on procurement behavior, user needs, and operational constraints. The methodology included supply-chain mapping to identify critical nodes and points of vulnerability, as well as design and usability assessments to evaluate how product attributes align with real-world administration scenarios.

Data triangulation and cross-validation steps were employed to reconcile discrepancies between commercial accounts and technical specifications, and peer review by subject-matter experts ensured that regulatory interpretations and clinical implications were accurately represented. The research also incorporated scenario analysis to explore implications of tariff adjustments, regional production shifts, and channel migration toward online dispensing. Ethical protocols and confidentiality protections were maintained during primary data collection to preserve commercial sensitivities and encourage candid stakeholder input.

Concluding synthesis emphasizing the integrated role of design excellence, supply-chain resilience, and strategic commercialization in securing long-term advantage

The converging pressures of material innovation, shifts in care delivery, and heightened procurement vigilance are redefining the competitive landscape for oral syringes. Manufacturers that align product design with caregiver and patient usability while safeguarding chemical compatibility will find greater acceptance across diverse end-user segments. Simultaneously, supply-chain resilience-achieved through supplier diversification, regional sourcing, and inventory strategies-remains essential to mitigate the operational impacts of trade policy changes and logistics disruptions.

Commercial success will require an integrated approach that pairs validated clinical benefits with clear value propositions for procurers and pharmacists. Companies that proactively invest in regulatory readiness, engage distribution partners effectively, and demonstrate measurable reductions in dosing errors will be best positioned to capture growing demand in home and outpatient environments. In sum, the path to sustainable advantage lies at the intersection of technical rigor, user-centered design, and strategic commercial partnerships that translate device improvements into better patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oral Syringes Market, by Material

  • 8.1. Glass
  • 8.2. Plastic

9. Oral Syringes Market, by End User

  • 9.1. Clinics
  • 9.2. Home Healthcare
    • 9.2.1. Caregiver Administered
    • 9.2.2. Self Administered
  • 9.3. Hospitals
    • 9.3.1. Private
    • 9.3.2. Public
  • 9.4. Pharmacies

10. Oral Syringes Market, by Application

  • 10.1. Human
  • 10.2. Veterinary

11. Oral Syringes Market, by Distribution Channel

  • 11.1. Offline Pharmacy
    • 11.1.1. Chain Pharmacy
    • 11.1.2. Independent Pharmacy
  • 11.2. Online Pharmacy
    • 11.2.1. E-commerce Platforms
    • 11.2.2. Pharmacy Websites

12. Oral Syringes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Oral Syringes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Oral Syringes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Oral Syringes Market

16. China Oral Syringes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Amsino International, Inc.
  • 17.6. AptarGroup, Inc.
  • 17.7. B. Braun Melsungen AG
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cardinal Health, Inc.
  • 17.10. Gerresheimer AG
  • 17.11. ICU Medical, Inc.
  • 17.12. Kindly (KDL) Group
  • 17.13. Medisafe UK Ltd
  • 17.14. Medline Industries, LP
  • 17.15. Nemera SA
  • 17.16. Nipro Corporation
  • 17.17. Owen Mumford Ltd.
  • 17.18. Retractable Technologies, Inc.
  • 17.19. SCHOTT AG
  • 17.20. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ORAL SYRINGES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ORAL SYRINGES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ORAL SYRINGES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ORAL SYRINGES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ORAL SYRINGES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ORAL SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ORAL SYRINGES MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ORAL SYRINGES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORAL SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORAL SYRINGES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORAL SYRINGES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORAL SYRINGES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORAL SYRINGES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ORAL SYRINGES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ORAL SYRINGES MARKET SIZE, BY CAREGIVER ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ORAL SYRINGES MARKET SIZE, BY CAREGIVER ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORAL SYRINGES MARKET SIZE, BY CAREGIVER ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORAL SYRINGES MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORAL SYRINGES MARKET SIZE, BY SELF ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ORAL SYRINGES MARKET SIZE, BY SELF ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ORAL SYRINGES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ORAL SYRINGES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ORAL SYRINGES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ORAL SYRINGES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ORAL SYRINGES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ORAL SYRINGES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ORAL SYRINGES MARKET SIZE, BY HUMAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORAL SYRINGES MARKET SIZE, BY HUMAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORAL SYRINGES MARKET SIZE, BY HUMAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORAL SYRINGES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ORAL SYRINGES MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ORAL SYRINGES MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ORAL SYRINGES MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORAL SYRINGES MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORAL SYRINGES MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORAL SYRINGES MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ORAL SYRINGES MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ORAL SYRINGES MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORAL SYRINGES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ORAL SYRINGES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ORAL SYRINGES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ORAL SYRINGES MARKET SIZE, BY PHARMACY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORAL SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ORAL SYRINGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ORAL SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. NATO ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ORAL SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA ORAL SYRINGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA ORAL SYRINGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA ORAL SYRINGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA ORAL SYRINGES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA ORAL SYRINGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA ORAL SYRINGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ORAL SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ORAL SYRINGES MARKET SIZE, BY OFFLINE PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ORAL SYRINGES MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)